Marek's disease
A viral disease affecting chickens
Marek's disease is a highly contagious viral disease in chickens caused by an alphaherpesvirus known as Gallid alphaherpesvirus 2. It is characterized by the presence of lymphomas, immunosuppression, and neurological symptoms. The disease is named after the Hungarian veterinarian József Marek, who first described the condition in 1907.
Virology[edit]
Marek's disease is caused by a herpesvirus that primarily affects chickens, although it can also infect other poultry species. The virus is classified into three serotypes:
- Serotype 1: Oncogenic strains that cause the disease.
- Serotype 2: Non-oncogenic strains found in chickens.
- Serotype 3: Non-oncogenic strains found in turkeys.
The virus is transmitted through aerosols and fomites, with infected birds shedding the virus in feather dander.
Pathogenesis[edit]
The pathogenesis of Marek's disease involves several stages:
- Early infection: The virus infects the respiratory tract and spreads to lymphoid tissue.
- Latent infection: The virus establishes latency in T cells.
- Reactivation: The virus reactivates, leading to lymphoproliferative disease.
Clinical Signs[edit]

Clinical signs of Marek's disease vary depending on the form of the disease:
- Neurological form: Paralysis, ataxia, and torticollis.
- Visceral form: Tumors in organs such as the liver, spleen, and kidneys.
- Ocular form: Changes in the iris leading to "gray eye" or ocular Marek's disease.
- Cutaneous form: Nodular lesions on the skin.
Diagnosis[edit]
Diagnosis of Marek's disease is based on clinical signs, histopathology, and polymerase chain reaction (PCR) testing. The presence of lymphoid tumors and enlarged nerves are indicative of the disease.
Prevention and Control[edit]
The primary method of controlling Marek's disease is through vaccination. Vaccines are typically administered to day-old chicks and provide protection against the oncogenic strains of the virus. Good biosecurity practices are also essential to prevent the spread of the virus.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian